ZeptoMetrix is the industry leader for innovative solutions to challenges in the evolving Infectious Disease Diagnostics market. Our reputation for product quality, reliability, and trusted technical knowledge provide assurance that enables our industry to develop and advance diagnostics technologies.
From assay conception to launch, our scientific and operational teams provide our customers with comprehensive, performance-oriented, and cost-effective products and services that positively impact the field of clinical diagnostics and its contribution to global healthcare.
ZeptoMetrix manufactures and provides an extensive range of controls and calibrators for serological assays and NAT. Its patented NATtrol products exceed current NAT standards and set an unparalleled benchmark in molecular testing. Prepared from highly purified viruses and treated to alter surface proteins, NATtrol products allow the viral nucleic acid to remain intact for testing. NATtrol products are noninfectious, refrigerator stable, control for all steps in NAT including centrifugation, extraction, amplification, and detection and work cohesively with all amplification assay formats.
United States clinical laboratories are required to follow federal regulations established by CLIA when validating IVD assays. This ensures optimal laboratory practices and accuracy of test results before clinical application and ensures continued quality practices and results once the test is run clinically.
NATtrol SARS-CoV-2 (recombinant) Stock* is formulated with purified, intact bacterial cells containing synthetic SARS-CoV-2 N gene sequence. The cells have been chemically modified to render them non-infectious and refrigerator stable. Each vial contains 1.0 mL of NATtrol SARS-CoV-2 (recombinant) Stock in a purified protein matrix.